Polycythemia vera‐associated pruritus and its management
Open Access
- 5 August 2010
- journal article
- review article
- Published by Wiley in European Journal of Clinical Investigation
- Vol. 40 (9) , 828-834
Abstract
Eur J Clin Invest 2010; 40 (9): 828–834 Background Pruritus is a defining feature of polycythemia vera (PV) and is seen in approximately 40% of patients. In most cases, the pruritus is characteristically triggered by contact with water (aquagenic) at any temperature.Materials and methods A detailed MEDLINE search for all English language articles related to PV, PV‐associated pruritus and aquagenic pruritus that were published from 1965 till date was carried out.Results Many different treatment options have been tried over the past several decades, including antihistamines, antidepressants, interferon alpha, phlebotomy, phototherapy, iron supplements and myelosuppressive medications, all demonstrating mixed results. Recently, agents that target JAK2 and mammalian target of rapamycin (mTOR) have shown impressive clinical benefit.Conclusion PV‐associated pruritus is a major cause of morbidity amongst patients with PV. Antidepressant medications interfering with serotonin uptake are somewhat efficacious. Cytoreductive therapy is reserved for refractory cases. Targeted therapy with JAK2 and mTOR inhibitors offers renewed hope.Keywords
This publication has 55 references indexed in Scilit:
- The JAK2V617 mutation induces constitutive activation and agonist hypersensitivity in basophils from patients with polycythemia veraHaematologica, 2009
- Involvement of mast cells by the malignant process in patients with Philadelphia chromosome negative myeloproliferative neoplasmsLeukemia, 2009
- Pruritus in polycythemia vera is associated with a lower risk of arterial thrombosisAmerican Journal of Hematology, 2008
- Cutaneous mononuclear cells and eosinophils are significantly increased after warm water challenge in pruritic areas of polycythemia veraJournal of Cutaneous Pathology, 2007
- A Gain-of-Function Mutation ofJAK2in Myeloproliferative DisordersNew England Journal of Medicine, 2005
- Cutaneous sarcoidosis and polycythemia veraJournal of the European Academy of Dermatology and Venereology, 2004
- Relief of intractable pruritus in polycythemia vera with recombinant interferon alfaAmerican Journal of Hematology, 1993
- Pruritus secondary to hydroxyurea therapy in a woman with polycythemia veraAmerican Journal of Hematology, 1992
- Variations in aquagenic pruritus and treatment alternativesJournal of the American Academy of Dermatology, 1988
- Aquagenic pruritusJournal of the American Academy of Dermatology, 1985